OPEN END TURBO OPTIONSSCHEIN SHORT - MERCK & CO. | Delayed Börse Stuttgart 08:12:06 23/05/2024 BST | ||
| 3.17 EUR | 0.00% |
|
| Current month | -6.21% | ||
| 1 month | -11.70% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 3.17 | 0.00% |
| 22/05/24 | 3.17 | -0.63% |
| 21/05/24 | 3.19 | +0.95% |
| 20/05/24 | 3.16 | +0.32% |
| 17/05/24 | 3.15 | -0.32% |
Delayed Quote Börse Stuttgart
Last update May 23, 2024 at 08:12 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GG5T25 |
| ISIN | DE000GG5T253 |
| Date issued | 25/03/2024 |
| Strike | 165.3 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 3.81 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.78 € |
|---|---|
| Lowest since issue | 3.03 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.1
USD
Average target price
141.6
USD
Spread / Average Target
+8.04%
- Stock Market
- Certificates
- Certificat
